Allspring Global Investments Holdings LLC Decreases Stake in Addus HomeCare Co. (NASDAQ:ADUS)

Allspring Global Investments Holdings LLC cut its stake in shares of Addus HomeCare Co. (NASDAQ:ADUSFree Report) by 87.1% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 4,922 shares of the company’s stock after selling 33,275 shares during the quarter. Allspring Global Investments Holdings LLC’s holdings in Addus HomeCare were worth $509,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Vanguard Group Inc. lifted its holdings in Addus HomeCare by 3.2% in the fourth quarter. Vanguard Group Inc. now owns 1,257,440 shares of the company’s stock valued at $116,753,000 after acquiring an additional 38,876 shares during the period. Wellington Management Group LLP boosted its position in Addus HomeCare by 1.2% during the fourth quarter. Wellington Management Group LLP now owns 798,435 shares of the company’s stock worth $74,135,000 after purchasing an additional 9,548 shares in the last quarter. Dimensional Fund Advisors LP grew its holdings in Addus HomeCare by 0.8% in the fourth quarter. Dimensional Fund Advisors LP now owns 698,498 shares of the company’s stock valued at $64,857,000 after purchasing an additional 5,654 shares during the period. TimesSquare Capital Management LLC increased its position in shares of Addus HomeCare by 13.0% in the fourth quarter. TimesSquare Capital Management LLC now owns 264,088 shares of the company’s stock valued at $24,521,000 after buying an additional 30,330 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its position in shares of Addus HomeCare by 7.4% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 179,635 shares of the company’s stock valued at $16,679,000 after buying an additional 12,392 shares in the last quarter. Hedge funds and other institutional investors own 95.35% of the company’s stock.

Analyst Upgrades and Downgrades

ADUS has been the topic of several research analyst reports. StockNews.com lowered shares of Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research report on Sunday. TD Cowen boosted their price objective on Addus HomeCare from $119.00 to $128.00 and gave the stock a “buy” rating in a research note on Tuesday, June 18th. Barclays lowered Addus HomeCare from an “equal weight” rating to an “underweight” rating and set a $83.00 price target on the stock. in a research note on Tuesday, April 23rd. Macquarie assumed coverage on shares of Addus HomeCare in a research report on Friday, June 28th. They set an “outperform” rating and a $136.00 price target on the stock. Finally, Bank of America raised their target price on shares of Addus HomeCare from $115.00 to $118.00 and gave the stock a “buy” rating in a research note on Tuesday, May 7th. One investment analyst has rated the stock with a sell rating and nine have given a buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $116.25.

Get Our Latest Analysis on Addus HomeCare

Insider Buying and Selling

In other Addus HomeCare news, EVP Roberton James Stevenson sold 217 shares of the business’s stock in a transaction that occurred on Monday, June 17th. The stock was sold at an average price of $116.13, for a total value of $25,200.21. Following the sale, the executive vice president now owns 10,217 shares of the company’s stock, valued at $1,186,500.21. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 4.60% of the stock is currently owned by corporate insiders.

Addus HomeCare Trading Down 1.6 %

ADUS opened at $116.95 on Wednesday. The stock has a market capitalization of $1.91 billion, a PE ratio of 29.02, a P/E/G ratio of 2.27 and a beta of 1.01. Addus HomeCare Co. has a one year low of $78.35 and a one year high of $120.53. The company has a debt-to-equity ratio of 0.14, a quick ratio of 1.35 and a current ratio of 1.35. The business’s 50 day moving average price is $112.92 and its 200 day moving average price is $101.06.

Addus HomeCare (NASDAQ:ADUSGet Free Report) last announced its earnings results on Monday, May 6th. The company reported $1.21 earnings per share for the quarter, topping the consensus estimate of $0.97 by $0.24. The company had revenue of $280.70 million during the quarter, compared to analyst estimates of $279.49 million. Addus HomeCare had a net margin of 6.04% and a return on equity of 10.03%. Addus HomeCare’s revenue was up 11.6% compared to the same quarter last year. During the same quarter last year, the firm posted $0.84 earnings per share. As a group, equities research analysts expect that Addus HomeCare Co. will post 4.36 EPS for the current year.

About Addus HomeCare

(Free Report)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

Featured Articles

Institutional Ownership by Quarter for Addus HomeCare (NASDAQ:ADUS)

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.